Skip to content

Author

A. Singanayagam

We have 2 of 66 papers

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Open access Sep 2026

Transmission-blocking vaccines for respiratory viruses: from concept to clinic

The obstacles to demonstrating transmission-blocking efficacy are outlined, from the absence of standardized correlates of protection to the limitations of animal and trial models, and how controlled human infection models, household studies, and field trials could help generate evidence to support regulatory engagemen...

A. Singanayagam · 0 citations
Open access Jul 2026

Biomarkers of protection against controlled human SARS-CoV-2 Delta variant breakthrough infection

Susceptibility to SARS-CoV-2 breakthrough infection in those with hybrid immunity is strongly associated with low levels of pre-existing antibody, but the diversity of immune markers associated with protection implies that additional benefits may be conferred by multi-pronged immunity.

A. Singanayagam, H. Wagstaffe, L. J. Slater et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.